Organisation paid for research Program year 2025 Source: CMS Open Payments

Melanie Palm MD PC

Neither a doctor nor a teaching hospital

Research payments

$663,062

79 payments

Through program year 2025, Melanie Palm MD PC is reported as receiving $663,062 in research payments, across 79 payments.

By program year

5 rows
Year Kind Amount Payments
2025 Research $76,230 6
2024 Research $24,644 9
2023 Research $102,610 20
2022 Research $110,791 20
2019 Research $348,788 24

Breakdown

Who paid Research payments · program years 2019–2025
  1. Allergan Inc. $348,788 24 payments
  2. AbbVie, Inc. $310,775 54 payments
  3. Galderma Laboratories, L.P. $3,500 1 payment
Studies the money was for Research payments · program years 2019–2025
  1. JUVEDERM VOLITE XC Injectable Gel for Fine Lines on the Cheek $130,768 8 payments
  2. A Phase 1, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of Agn-151607 After Single Intramuscular Treatment in Subjects With Glabellar Lines $100,159 4 payments
  3. PH 3 Pivotal LCL and GL and LCL - Useu $92,345 6 payments
  4. A Study to Assess Adverse Events and Change in Disease Activity of JUVEDERM VOLITE XC Injectable Gel for Change in Neck Appearance in Adult Participants $83,181 16 payments
  5. A prospective, multi-center, evaluator and subject-blinded, randomized, comparator-controlled, parallel design study to evaluate the safety and effectiveness of NOA LIFT compared to JUVeDERM VOLLURE XC for the correction of facial wrinkles and folds $80,924 5 payments
  6. A Study to Assess Adverse Events and Change in Disease Activity of JUV?DERM? VOLITE? XC Injectable Gel for Change in Neck Appearance in Adult Participants $51,506 6 payments
  7. A Study To Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Moderate to Severe Platysma Prominence $47,420 10 payments
  8. A Study To Assess the Safety of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Platysma Prominence $30,840 13 payments
  9. A multicenter, single-blind, randomized, controlled study of the safety and effectiveness of Juvederm VOLBELLA XC injectable gel for correction of infraorbital hollowing $16,055 3 payments
  10. A Study to Assess Adverse Events and Change in Disease Activity of JUV/DERM/ VOLITE/XC Injectable Gel for Change in Neck Appearance in Adult Participants $15,319 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record